International gelistet Medline-Publikationen

Publikationen

Hier finden Sie Publikationen von Prof. Naim und Mitarbeitern:

  1. Naim R, Riedel F, Bran G, Hörmann K. Expression of beta-catenin in external auditory canal cholesteatoma (EACC). Biofactors 2003;19(3-4):189-95.
  2. Naim R, Riedel F, Hormann K. Expression of vascular endothelial growth factor in external auditory canal cholesteatoma. Int J Mol Med 2003, May;11(5):555-8.
  3. Sadick H, Naim R, Ramin N, Oulmi J, Hörmann K, Karl H, Bergler W. Plasma surgery and topical estriol: Effects on the nasal mucosa and long-term results in patients with osler's disease. Otolaryngol Head Neck Surg 2003, Sep;129(3):233-8.
  4. Sadick H, Riedel F, Naim R, Gössler U, Hörmann K, Bergler WF. Benign mixed tumor of the lacrimal gland. Clinical diagnosis and surgical management. ORL J Otorhinolaryngol Relat Spec 2003;65(5):295-9.
  5. Naim R, Riedel F, Bran G, Sadick H, Hörmann K. [Cell adhesion proteins in external auditory canal cholesteatoma]. HNO 2004, Dec;52(12):1083-7.
  6. Naim R, Linthicum FH. External auditory canal cholesteatoma. Otol Neurotol 2004, May;25(3):412-3.
  7. Naim R, Riedel F, Gotte K, Bran G, Sadick H, Gossler U, Hormann K. Co-expression of different angiogenic factors in external auditory canal cholesteatoma. Acta Otolaryngol 2004, Jun;124(5):563-8.
  8. Naim R, Sadick H, Schafer C, Hormann K. External auditory canal cholesteatoma: Analysis of the integrity of the tissue structure. Int J Mol Med 2004, Oct;14(4):601-4.
  9. Naim R, Tolnay E, Mueller KM, Kuhnen C. Co-expression of VEGF, c-met and HGF/SF in secondary pleural tumors. Int J Mol Med 2004, Nov;14(5):787-91.
  10. Naim R, Steinhoff I, Hörmann K, Maurer JT. Ossifying haemangioma of the frontal sinus. ORL J Otorhinolaryngol Relat Spec 2004;66(2):98-100.
  11. Naim R, Chang RC, Alfano SS, Riedel F, Bayerl C, Sadick H, et al. Targeting tgf-beta1 increases hepatocyte growth factor (HGF/SF) levels in external auditory canal cholesteatoma (EACC) epithelial cell culture. Regul Pept 2005, Aug 15;130(1-2):75-80.
  12. Sadick H, Naim R, Gössler U, Hörmann K, Riedel F. Angiogenesis in hereditary hemorrhagic telangiectasia: VEGF165 plasma concentration in correlation to the VEGF expression and microvessel density. Int J Mol Med 2005, Jan;15(1):15-9.
  13. Naim R, Chang RC, Sadick H, Bayerl C, Bran G, Hormann K. Effect of vascular endothelial growth factor on fibroblasts from external auditory canal cholesteatoma. Arch Med Res 2005;36(5):518-23.
  14. Naim R, Sadick H, Bayerl C, Riedel F, Schafer C, Bran G, Hormann K. Hepatocyte growth factor/scatter factor induces VEGF in human external auditory canal cholesteatoma cell culture. Int J Mol Med 2005, Jan;15(1):67-71.
  15. Naim R, Chang RC, Sadick H, Hormann K. Influence of hepatocyte growth factor/scatter factor (HGF/SF) on fibroblast growth factor-2 (FGF-2) levels in external auditory canal cholesteatoma (EACC) cell culture. In Vivo 2005;19(3):599-603.
  16. Naim R, Chang RC, Anders C, Sadick H, Riedel F, Bayerl C, et al. Up-regulation of beta-catenin in external auditory canal cholesteatoma. Int J Mol Med 2005, May;15(5):801-4.
  17. Sadick H, Naim R, Sadick M, Hörmann K, Riedel F. Plasma level and tissue expression of angiogenic factors in patients with hereditary hemorrhagic telangiectasia. Int J Mol Med 2005, Apr;15(4):591-6.
  18. Sadick H, Bergler WF, Oulmi-Kagermann J, Naim R, Sadick M, Hörmann K, Riedel F. Estriol induced squamous metaplasia on the nasal mucosa in patients with hereditary hemorrhagic telangiectasia. Arch Med Res 2005;36(5):468-73.
  19. Naim R, Sadick H, Bayerl C, Bran G, Hörmann K. [Angiogenic factors in external auditory canal cholesteatoma-fibroblast cell culture]. HNO 2005, Nov;53(11):952-6.
  20. Riedel F, Zaiss I, Herzog D, Götte K, Naim R, Hörmann K. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma. Anticancer Res 2005;25(4):2761-5.
  21. Goessler UR, Bieback K, Bugert P, Naim R, Schafer C, Sadick H, et al. Human chondrocytes differentially express matrix modulators during in vitro expansion for tissue engineering. Int J Mol Med 2005, Oct;16(4):509-15.
  22. Naim R, Shen T, Riedel F, Bran G, Sadick H, Hormann K. Regulation of apoptosis in external auditory canal cholesteatoma by hepatocyte growth factor/scatter factor. ORL J Otorhinolaryngol Relat Spec 2005;67(1):45-50.
  23. Sadick H, Riedel F, Naim R, Goessler U, Hörmann K, Hafner M, Lux A. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression. Haematologica 2005, Jun;90(6):818-28.
  24. Naim R, Linthicum F, Shen T, Bran G, Hormann K. Classification of the external auditory canal cholesteatoma. Laryngoscope 2005, Mar;115(3):455-60.
  25. Sauter A, Riedel F, Hörmann K, Naim R. [Nasal congestion due to a painless mass of the left choana]. HNO 2006, Jul;54(7):550-2.
  26. Sadick H, Sadick M, Götte K, Naim R, Riedel F, Bran G, Hörmann K. Hereditary hemorrhagic telangiectasia: An update on clinical manifestations and diagnostic measures. Wien Klin Wochenschr 2006, Mar;118(3-4):72-80.
  27. Naim R, Chang RC, Schultz J, Hormann K. Chemopreventive alteration of the cell-cell adhesion in head and neck squamous cell cancer. Oncol Rep 2006, Aug;16(2):273-7.
  28. Naim R, Hormann K. The role of S100A1 in external auditory canal cholesteatoma. Oncol Rep 2006, Oct;16(4):671-5.
  29. Naim R, Sadick H, Sauter A, Hörmann K. [Middle-ear adenoma]. Laryngorhinootologie 2006, Jan;85(1):46-9.
  30. Blum A, Back W, Naim R, Hörmann K, Riedel F. Ossifying fibromyxoid tumor of the nasal septum. Auris Nasus Larynx 2006, Sep;33(3):325-7.
  31. Sauter A, Lambert KL, Rupf AK, Von Specht BU, Hörmann K, Naim R. A three-step purification method of large quantities of human recombinant alpha endothelial cellular growth factor for clinical use. Int J Mol Med 2007, Jan;19(1):97-103.
  32. Bloching MB, Barnes J, Aust W, Knipping S, Neumann K, Grummt T, Naim R. Saliva as a biomarker for head and neck squamous cell carcinoma: In vitro detection of cytotoxic effects by using the plating efficiency index. Oncol Rep 2007, Dec;18(6):1551-6.
  33. Sauter A, Matharu R, Hörmann K, Naim R. Current advances in the basic research and clinical management of sinonasal inverted papilloma (review). Oncol Rep 2007, Mar;17(3):495-504.
  34. Sauter A, Bersch C, Lambert KL, Hörmann K, Naim R. Chondrosarcoma of the larynx and review of the literature. Anticancer Res 2007;27(4C):2925-9.
  35. Sauter A, Matharu R, Braun T, Schultz J, Sadick H, Hormann K, Naim R. Sulindac sulfone modulates beta-catenin in human cholesteatoma cell culture. Arch Med Res 2007, May;38(4):367-71.
  36. Sauter A, Bas-Orth D, Stern-Straeter J, Barnes J, Soulsby H, Hörmann K, Naim R. Effect of vascular cell adhesion molecule 1 on fibroblasts in human eosinophilic chronic rhinosinusitis. Int J Mol Med 2008, Oct;22(4):441-6.
  37. Naim R, Braun T, Sauter A, Barnes J, Aust W, Naumann A, et al. VCAM-1 increases levels of HGF in eosinophilic chronic rhinosinusitis cell culture. In Vivo 2008;22(1):77-81.
  38. Naim R, Naumann A, Barnes J, Sauter A, Hormann K, Merkel D, et al. Transforming growth factor-beta1-antisense modulates the expression of hepatocyte growth factor/scatter factor in keloid fibroblast cell culture. Aesthetic Plast Surg 2008, Mar;32(2):346-52.
  39. Sauter A, Barnes J, Stern-Straeter J, Hörmann K, Naim R. In vitro study of interleukin-5 (IL-5) in human eosinophilic chronic rhinosinusitis cell culture. In Vivo 2008;22(5):549-56.
  40. Naim R. [Photodynamic therapy using m-thpc (foscan). Treatment of head and neck squamous cell carcinoma]. HNO 2008, May;56(5):490-2.
  41. Sauter A, Stern-Straeter J, Chang RC, Hörmann K, Naim R. Influence of interleukin-13 on beta-catenin levels in eosinophilic chronic rhinosinusitis cell culture. Int J Mol Med 2008, Apr;21(4):447-52.
  42. Bloching MM, Soulsby H, Naumann A, Aust W, Merkel D, Braun T, Naim R. Tumor risk assessment by means of immunocytochemical detection of early pre-malignant changes in buccal smears. Oncol Rep 2008, Jun;19(6):1373-9.
  43. Sauter A, Stern-Straeter J, Sodha S, Hörmann K, Naim R. Regulation of matrix metalloproteinases (MMP)-2/-9 expression in eosinophilic chronic rhinosinusitis--cell culture by interleukin-5 and -13? In Vivo 2008;22(4):415-21.
  44. Gieringer M, Elliott K, Gosepath J, Naim R. Keloids: Fundamental principles and prospects (review). Mol Med Rep 2010;3(1):13-9.
  45. Sauter A, Soulsby H, Hormann K, Naim R. Sulindac sulfone induces a decrease of beta-catenin in HNSCC. Anticancer Res 2010, Feb;30(2):339-43.
  46. Karniol R, Galili L, Shtilerman D, Naim R, Stern K, Manjoch H, Silverman R. Why superman can wait: Cognitive self-transformation in the delay of gratification paradigm. J Clin Child Adolesc Psychol 2011;40(2):307-17.
  47. Gieringer M, Naim R, Fisseler-Eckhoff A, Gosepath J. [Uncommon differential diagnosis of persistent otorrhea]. Laryngorhinootologie 2011, Aug;90(8):487-8.
  48. Gieringer M, Gosepath J, Naim R. Radiotherapy and wound healing: Principles, management and prospects (review). Oncol Rep 2011, Aug;26(2):299-307.
Newsletter

Seien Sie auf dem Laufenden mit den aktuellsten HNO Neuigkeiten!